FIELD: veterinary science; medicine; pharmaceutical industry.
SUBSTANCE: invention can be used for treating viral ectromelia disease. Disclosed is use of amphiphilic high-polymer yeast RNA, packed in nanosized chitosan capsules with drug substance content in them 30–50%, as an antiviral oral agent for treating ectromelia.
EFFECT: invention provides the possibility of painless oral administration of the antiviral preparation, the efficacy of which is not less than that of intramuscular administration.
1 cl, 2 tbl, 1 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF TREATING POX | 2012 |
|
RU2480219C1 |
METHOD OF PRODUCING AMPHIPHILIC HIGHLY POLYMERIC RNA FROM DRY YEAST | 2022 |
|
RU2801533C1 |
METHOD OF TREATING AVIAN INFLUENZA | 2012 |
|
RU2502512C2 |
METHOD OF HIGH-POLYMERIC RNA MANUFACTURE FROM YEAST | 2008 |
|
RU2392328C2 |
ANTIVIRAL AGENT FOR PREVENTION OF INFECTIOUS BOVINE RHINOTRACHEITIS | 2014 |
|
RU2571935C1 |
AMPHIPHILIC HIGH-POLYMER RNA FROM BAKER'S YEAST | 2009 |
|
RU2430968C2 |
ANTIVIRAL AGENT | 2010 |
|
RU2436583C1 |
HIGH-POLYMER RNA FROM BAKER'S YEAST, FREE FROM IMPURITY ASSOCIATIONS OF RNA WITH PROTEINS AND POLYSACCHARIDES | 2009 |
|
RU2430969C2 |
METHOD OF HIGH-POLYMERIC RNA MANUFACTURE FROM YEAST | 2008 |
|
RU2392329C1 |
METHOD OF PRODUCING HIGH-POLYMERIC RNA FROM DRY BAKER'S YEAST | 2009 |
|
RU2403288C1 |
Authors
Dates
2024-07-30—Published
2023-10-25—Filed